Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, November 22, 2019
Heraeus Pharmaceutical Ingredients has expanded its capacity for Platinum-based highly potent active pharmaceutical ingredients with an additional production line built at the company’s headquarters in Hanau, Germany.
read more
Heraeus Pharmaceutical Ingredients’ additional production line for Platinum-based highly potent active pharmaceutical ingredients (Pt hAPIs) is now fully operational at the company’s headquarters in Hanau, Germany. Heraeus, a business line of Heraeus...
read more
HCATS and apceth Biopharma have expanded their relationship with bluebird bio with long-term development and manufacturing services agreements for clinical and commercial supply for multiple therapies.
read more
Granules voluntarily recalling 12 lots of Metformin Hydrochloride Extended-Release Tablets due to the detection of NDMA levels above the Acceptable Daily Intake Limit.
read more
Grand River Aseptic Manufacturing expands its capabilities in syringe filling at its FDA-inspected, cGMP-compliant manufacturing facility in Grand Rapids, Mich.
read more
Wednesday, March 03, 2021
Grace has entered into a definitive agreement to acquire the Fine Chemistry Services business of Albemarle for approximately $570 million.
read more
Gilead Sciences and Nurix Therapeutics announced a collaboration to discover, develop and commercialize a pipeline of targeted protein degradation drugs for patients with cancer.
read more
Monday, December 30, 2019
Gilead Sciences and Eisai announced the two companies have entered into an agreement for the distribution and co-promotion of filgotinib, pending regulatory approval for rheumatoid arthritis.
read more
Tuesday, September 01, 2020
Gilead Sciences announced an agreement with Jounce Therapeutics to exclusively license its JTX-1811 program.
read more
Wednesday, January 29, 2020
GeoVax Labs and BravoVax announced the signing of a Letter of Intent to jointly develop a vaccine against the new coronavirus (known as 2019-nCoV).
read more
Thursday, January 23, 2020
Genome & Company has entered into a clinical trial collaboration and supply agreement with Merck KGaA and Pfizer to evaluate GEN-001 therapy in combination with avelumab.
read more
Ajinomoto Bio-Pharma Services announced GeneDesign has joined the global organization.
read more
Monday, September 25, 2017
Geisinger and Boehringer Ingelheim announced a collaboration to develop a risk-prediction model for three critical health outcomes commonly associated with type 2 diabetes that have long-term impact.
read more
Thursday, November 17, 2022
GE Healthcare’s Pharmaceutical Diagnostics business announced an $80 million investment to increase manufacturing capacity by 30 percent at its Active Pharmaceutical Ingredients (API) site in Lindesnes, Norway.
read more
Monday, December 07, 2020
Fresenius Kabi USA is voluntarily recalling a single lot of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg/50 mL (4 mcg /mL), 50 mL fill in a 50 mL vial.
read more